A recent analysis of 300 trials showed that patients in clinical trials were, on average, 6.5 years younger than the population for whom the drug was intended.
MDedge News
Few Patient Over 65 in Cancer Clinical Trials: Why?
A recent analysis of 300 trials showed that patients in clinical trials were, on average, 6.5 years younger than the population for whom the drug was intended.
MDedge News
